Quantum-Si incorporated
$1.01
▲
0.03%
2026-04-21 09:02:00
www.quantum-si.com
NGM: QSI
Explore Quantum-Si incorporated stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$231.51 M
Current Price
$1.01
52W High / Low
$3.1 / $0.69
Stock P/E
—
Book Value
$1.02
Dividend Yield
—
ROCE
-43.74%
ROE
-46.52%
Face Value
—
EPS
$-0.51
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
145
Beta
3.09
Debt / Equity
1.89
Current Ratio
7.64
Quick Ratio
7.5
Forward P/E
-2
Price / Sales
65.77
Enterprise Value
$1.48 M
EV / EBITDA
-0.02
EV / Revenue
0.61
Rating
None
Target Price
$2.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Penumbra, Inc. | $333.46 | 73.7 | $13.1 B | — | 11.52% | 13.78% | $362.41 / $221.26 | $36.39 |
| 2. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 3. | Bio-Rad Laboratories, Inc. | NOT FOUND | — | — | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 4. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 5. | Elutia Inc. | $1.12 | 0.92 | $49.2 M | — | -49.48% | -574.35% | $2.64 / $0.5 | $0.65 |
| 6. | Bluejay Diagnostics, Inc. | $1.97 | — | $1.94 M | — | -115.88% | -1.17% | $16.68 / $1.65 | $9.88 |
| 7. | PROCEPT BioRobotics Corporation | $25.73 | — | $1.45 B | — | -23.48% | -24.89% | $66.85 / $19.35 | $6.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.45 M | 0.55 M | 0.59 M | 0.84 M | 1.19 M | — |
| Operating Profit | -21.09 M | -24.4 M | -26.76 M | -25.11 M | -30.68 M | — |
| Net Profit | -17.61 M | -35.7 M | -28.84 M | -19.19 M | -33.12 M | — |
| EPS in Rs | -0.09 | -0.18 | -0.15 | -0.1 | -0.17 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.44 M | 3.06 M | 1.08 M | 0 M |
| Operating Profit | -97.36 M | -108.58 M | -111.17 M | -114.36 M |
| Net Profit | -101.34 M | -101.01 M | -95.96 M | -132.44 M |
| EPS in Rs | -0.52 | -0.51 | -0.49 | -0.67 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 245.61 M | 247.87 M | 298.25 M | 391.49 M |
| Total Liabilities | 25.38 M | 32.45 M | 26.63 M | 32.78 M |
| Equity | 220.23 M | 215.42 M | 271.62 M | 358.71 M |
| Current Assets | 175.86 M | 218.01 M | 266.31 M | 358.18 M |
| Current Liabilities | 23.02 M | 18.19 M | 11.61 M | 15.71 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -94.72 M | -87.8 M | -94.04 M | -90.56 M |
| Investing CF | -28.32 M | -32.67 M | 143.43 M | 137.19 M |
| Financing CF | 95.42 M | 35.88 M | 0.15 M | 1.91 M |
| Free CF | -97.23 M | -92.44 M | -99.31 M | -101.3 M |
| Capex | -2.52 M | -4.64 M | -5.27 M | -10.74 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 182.62% | — | — | — |
| Earnings Growth % | -5.26% | 27.55% | — | — |
| Profit Margin % | -3303.04% | -8868.76% | — | — |
| Operating Margin % | -3550.56% | -10274.58% | — | — |
| Gross Margin % | 52.32% | 45.1% | — | — |
| EBITDA Margin % | -3400.13% | -9890.48% | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.